These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38001940)

  • 1. Comparative Efficacy of Metformin and Glimepiride in Modulating Pharmacological Network to Increase BDNF Levels and Benefit Type 2 Diabetes-Related Cognitive Impairment.
    Anirudhan A; Ahmad SF; Emran TB; Angulo-Bejarano PI; Sharma A; Ahmed SSSJ
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence.
    Sahay RK; Mittal V; Gopal GR; Kota S; Goyal G; Abhyankar M; Revenkar S
    Cureus; 2020 Sep; 12(9):e10700. PubMed ID: 33133865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials.
    Zhu H; Zhu S; Zhang X; Guo Y; Shi Y; Chen Z; Leung SW
    Diabetol Metab Syndr; 2013 Nov; 5(1):70. PubMed ID: 24228743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin.
    Abdelwahed OM; Tork OM; Gamal El Din MM; Rashed L; Zickri M
    Brain Res Bull; 2018 May; 139():67-80. PubMed ID: 29421245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study.
    Yoon KH; Shin JA; Kwon HS; Lee SH; Min KW; Ahn YB; Yoo SJ; Ahn KJ; Park SW; Lee KW; Sung YA; Park TS; Kim MS; Kim YK; Nam MS; Kim HS; Park IeB; Park JS; Woo JT; Son HY
    Diabetes Metab J; 2011 Feb; 35(1):26-33. PubMed ID: 21537410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin.
    Derosa G; Franzetti I; Gadaleta G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Jun; 17(3):143-50. PubMed ID: 15334791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utilization Pattern of Multiple Strengths of Glimepiride and Metformin Fixed Dose Combinations in Indian Type 2 Diabetes Patients.
    Ag U; K P; J G; S V; Mv A
    J Assoc Physicians India; 2020 Jul; 68(7):57-61. PubMed ID: 32602682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus.
    Kim G; Oh S; Jin SM; Hur KY; Kim JH; Lee MK
    Expert Opin Pharmacother; 2017 Aug; 18(12):1179-1186. PubMed ID: 28714741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study.
    Kim JM; Kim SS; Kim JH; Kim MK; Kim TN; Lee SH; Lee CW; Park JY; Kim ES; Lee KJ; Choi YS; Kim DK; Kim IJ
    Diabetes Metab J; 2020 Feb; 44(1):67-77. PubMed ID: 31339011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes.
    Kabadi UM; Kabadi M
    Diabetes Res Clin Pract; 2006 Jun; 72(3):265-70. PubMed ID: 16406190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease.
    Werida R; Kabel M; Omran G; Shokry A; Mostafa T
    Diabetes Res Clin Pract; 2020 Dec; 170():108473. PubMed ID: 33002553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.
    Derosa G; Gaddi AV; Piccinni MN; Salvadeo S; Ciccarelli L; Fogari E; Ghelfi M; Ferrari I; Cicero AF
    Diabetes Obes Metab; 2006 Mar; 8(2):197-205. PubMed ID: 16448524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus.
    Xie J; Li N; Jiang X; Chai L; Chen JJ; Deng W
    Diabetes Metab Syndr Obes; 2019; 12():519-526. PubMed ID: 31114280
    [No Abstract]   [Full Text] [Related]  

  • 14. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.
    Gottschalk M; Danne T; Vlajnic A; Cara JF
    Diabetes Care; 2007 Apr; 30(4):790-4. PubMed ID: 17392540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
    Tang JZ; Mao JP; Yang ZF; Zhou ZG; Tang WL; Feng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition and BDNF levels in prediabetes and diabetes: A mediation analysis of a cross-sectional study.
    Sumbul-Sekerci B; Sekerci A; Pasin O; Durmus E; Yuksel-Salduz ZI
    Front Endocrinol (Lausanne); 2023; 14():1120127. PubMed ID: 36936159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM).
    Kesavadev J; Pillai PBS; Shankar A; Krishnan G; Jothydev S
    Endocr Connect; 2017 Nov; 6(8):748-757. PubMed ID: 28982699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARATIVE EFFECT OF INSULIN, GLIMEPIRIDE, AND METFORMIN ON INFLAMMATORY MARKERS IN TYPE 2 DIABETES MELLITUS.
    Alsadoon L; Abdullah K
    Georgian Med News; 2023 Feb; (335):60-63. PubMed ID: 37042590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
    Nauck M; Frid A; Hermansen K; Shah NS; Tankova T; Mitha IH; Zdravkovic M; Düring M; Matthews DR;
    Diabetes Care; 2009 Jan; 32(1):84-90. PubMed ID: 18931095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.